Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Meridia (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-10 of 10
» View wsbt.com items only
    Jun 27, 2012 |Story| Los Angeles Times

  1. FDA approves lorcaserin, first weight-loss drug since 1999

    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...

    Tags: Weight, High Cholesterol, Physical Fitness and Exercise, Pharmaceuticals, Heart Disease

    2. Aug 10, 2012 |Story| Chicago Tribune

  2. Dangerous pharmaceuticals marketed as supplements

    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle.
    Shengyang Zhou assured the American buyers that his Chinese-made weight-loss capsules were safe. Zhou was sure because he had a test — one person eats a whole bottle. Such a person would have "maybe some stomach problem, but not die," he told...

    Tags: Computing and Information Technology Industry, China, Orlistat (drug), Economy, Business and Finance, Companies and Corporations

    3. Mar 29, 2012 |Story| Reuters

  3. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Economy, Business and Finance, Companies and Corporations, Weight, Vivus Inc., Heart Disease

    4. Jul 11, 2011 | Los Angeles Times

  4. Consumer Confidential: Groupon is watching, diet-product warning, free Slurpees

    Money & Company
    Here's your monster-mash Monday roundup of consumer news from around the Web: --Groupon is watching you. The deal site is changing its privacy policies to allow it to collect more information as it offers more deals targeted to users based......
    5. Jan 4, 2011 |Story| KTLA-LTV

  5. FDA Warns Against 'Fruta Planta' Weight Loss Drug

    The FDA is warning consumers about a weight loss drug that could be deadly.
    KTLA News
    The FDA is warning consumers about a weight loss drug that could be deadly. Fruta Planta has been linked to several heart attacks and at least one death, according to officials. The maker of the product, Kissimmee-based PRock Marketing, is recalling all...

    Tags: Weight, KTLA, Heart Attack, Physical Conditions, Heart Failure

    6. Apr 3, 2010 |Story| Chicago Tribune

  6. Try this bedbug trap

    Q: How can I tell if my apartment is infested with bedbugs? A friend has just gone through a nightmare experience trying to get rid of them. She had to throw out her mattress, couch and other furniture, have the whole place fumigated and everything dry-cleaned. It cost thousands of dollars.
    King Features Syndicate
    Q: How can I tell if my apartment is infested with bedbugs? A friend has just gone through a nightmare experience trying to get rid of them. She had to throw out her mattress, couch and other furniture, have the whole place fumigated and everything dry-...

    Tags: Lotteries, Heart Attack, Nature, Health, Drugs and Medicines

    7. Jul 1, 2009 |Story| Tribune Media Services

  7. Tags: Oregon, Overweight, Weight Loss, Health and Safety at School, Dietary Supplements

    8. Sep 17, 2010 |Story| Los Angeles Times

  8. The scorecard on obesity drugs: 0 for 3

    This is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on prescription obesity drugs this year by the advisory committee.
    Los Angeles Times Staff Writer
    This is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...

    Tags: Elections, Weight, Pharmaceuticals, Obesity, Health

    9. Dec 3, 2009 | Los Angeles Times

  9. Consumer Confidential: Weighty pills, empty containers, junky ads

    Money & Company
    Here's your thrill-a-minit Thursday roundup of consumer news from around the Web: -- The consumer group Public Citizen is calling on federal regulators to ban the weight-loss pill Meridia because a recent study links it to an increased risk of......
    10. Jan 22, 2010 | Los Angeles Times

  10. Heart and stroke patients warned against use of weight-loss drug Meridia

    Booster Shots
    The FDA has issued a new warning on the weight-loss drug sibutramine (marketed as Meridia or Reductil), cautioning patients with a history of heart disease or an elevated stroke risk that use of the drug could further boost the likelihood......
Original site for Meridia (drug) topic gallery.